{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:24:15Z","timestamp":1781922255009,"version":"3.54.5"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,15]]},"DOI":"10.1097\/tp.0b013e318263ad7a","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T14:24:56Z","timestamp":1349965496000},"page":"1075-1084","source":"Crossref","is-referenced-by-count":47,"title":["HTLV-1 in Solid-Organ Transplantation"],"prefix":"10.1097","volume":"94","author":[{"given":"Matthew J.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.6981847","article-title":". A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.","volume":"218","author":"Kalyanaraman","year":"1982","journal-title":"Science"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":". Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"R3-1-20210129","first-page":"381","article-title":"An HTLV-I vaccine: why, how, for whom AIDS Res Hum R","volume":"9","author":"de The","year":"1993","journal-title":"etroviruses"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1128\/CMR.00021-07","article-title":". Transmission of tropical and geographically restricted infections during solid-organ transplantation.","volume":"21","author":"Martin-Davila","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(94)90994-6","article-title":"Human T-lymphotropic virus type I in Japan.","volume":"343","author":"Yamaguchi","year":"1994","journal-title":"Lancet"},{"key":"R6-1-20210129","first-page":"1102","article-title":". A study of HTLV-I and its associated risk factors in Trinidad and Tobago.","volume":"3","author":"Blattner","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/oxfordjournals.aje.a115824","article-title":". Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants.","volume":"133","author":"Murphy","year":"1991","journal-title":"Am J Epidemiol"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/aid.1991.7.447","article-title":". Seroepidemiology of human T-cell lymphotropic virus type III in Benin (West Africa).","volume":"7","author":"Dumas","year":"1991","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00126334-200501010-00018","article-title":". The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women.","volume":"38","author":"Taylor","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.284.2.229","article-title":". Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).","volume":"284","author":"Glynn","year":"2000","journal-title":"JAMA"},{"key":"R11-1-20210129","first-page":"1","article-title":"Human immunodeficiency viruses and human T-cell lymphotropic viruses.","volume":"67","year":"1996","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid1507.080796","article-title":". Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel.","volume":"15","author":"Stienlauf","year":"2009","journal-title":"Emerging Infect Dis"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-3148.2008.00902.x","article-title":". The introduction of anti-HTLV testing of blood donations and the risk of transfusion-transmitted HTLV, UK: 2002-2006.","volume":"19","author":"Davison","year":"2009","journal-title":"Transfus Med"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/viro.1997.9009","article-title":". Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO.","volume":"242","author":"Murphy","year":"1998","journal-title":"Virology"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0140-6736(98)09460-4","article-title":"Human T-lymphotropic virus type I infection.","volume":"353","author":"Manns","year":"1999","journal-title":"Lancet"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/ijc.2910430618","article-title":". Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers.","volume":"43","author":"Kondo","year":"1989","journal-title":"Int J Cancer"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ijc.2910430214","article-title":". Modelling the risk of adult T-cell leukemialymphoma in persons infected with human T-lymphotropic virus type I.","volume":"43","author":"Murphy","year":"1989","journal-title":"Int J Cancer"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00042560-199802010-00011","article-title":". Incidence of HTLV-I-associated myelopathytropical spastic paraparesis (HAMTSP) in Jamaica and Trinidad.","volume":"17","author":"Maloney","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R19-1-20210129","first-page":"144","article-title":"The epidemiology and disease outcomes of human T-lymphotropic virus type II.","volume":"6","author":"Roucoux","year":"2004","journal-title":"AIDS Rev"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":". Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemialymphoma showing improved survival in the leukemic subtypes.","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(90)92896-P","article-title":". Infective dermatitis of Jamaican children: a marker for HTLV-I infection.","volume":"336","author":"LaGrenade","year":"1990","journal-title":"Lancet"},{"key":"R23-1-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00055735-200312000-00016","article-title":"Ocular manifestations of human T-cell lymphotropic virus type 1 infection.","volume":"14","author":"Buggage","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"R24-1-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(89)90038-X","article-title":". Chronic inflammatory arthropathy associated with HTLV-I.","volume":"1","author":"Nishioka","year":"1989","journal-title":"Lancet"},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(06)70628-7","article-title":"The HTLV-1 neurological complex.","volume":"5","author":"Araujo","year":"2006","journal-title":"Lancet Neurol"},{"key":"R26-1-20210129","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0140-6736(87)91362-6","article-title":". T-lymphocyte alveolitis in HTLV-I-associated myelopathy.","volume":"2","author":"Sugimoto","year":"1987","journal-title":"Lancet"},{"key":"R27-1-20210129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1086\/510679","article-title":". Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathytropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.","volume":"44","author":"Silva","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R28-1-20210129","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1349-7006.1998.tb00631.x","article-title":". Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors.","volume":"89","author":"Arisawa","year":"1998","journal-title":"Jpn J Cancer Res"},{"key":"R29-1-20210129","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/jmv.21867","article-title":"Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use.","volume":"82","author":"Malm","year":"2010","journal-title":"J Med Virol"},{"key":"R30-1-20210129","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/01.tp.0000236031.03510.75","article-title":". High seroprevalence of anti-HTLV-III antibodies among solid organ donors necessitates confirmatory testing.","volume":"82","author":"Nowicki","year":"2006","journal-title":"Transplantation"},{"key":"R31-1-20210129","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1537-2995.2010.02903.x","article-title":". Human T-lymphotropic virus antibody screening of blood donors: rates of false-positive results and evaluation of a potential donor reentry algorithm.","volume":"51","author":"Stramer","year":"2011","journal-title":"Transfusion"},{"key":"R32-1-20210129","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1128\/JCM.00781-09","article-title":". Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination.","volume":"47","author":"Moens","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R33-1-20210129","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1125>3.0.CO;2-N","article-title":". Lymphoproliferative disorders in renal transplant patients in Japan.","volume":"91","author":"Hoshida","year":"2001","journal-title":"Int J Cancer"},{"key":"R34-1-20210129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00007890-200301150-00019","article-title":". Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor.","volume":"75","author":"Toro","year":"2003","journal-title":"Transplantation"},{"key":"R35-1-20210129","first-page":"695","article-title":". HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient.","volume":"48","author":"Zanke","year":"1989","journal-title":"Transplantation"},{"key":"R36-1-20210129","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/jnnp.71.6.818","article-title":". Human T lymphotropic virus type I (HTLV-1) associated myelopathy acquired through a liver transplant.","volume":"71","author":"Zarranz","year":"2001","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"R37-1-20210129","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0041-1345(98)00261-9","article-title":". Influence of immunosuppression in HTLV-1-positive renal transplant recipients.","volume":"30","author":"Nakamura","year":"1998","journal-title":"Transplant Proc"},{"key":"R38-1-20210129","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/S0041-1345(98)00980-4","article-title":". Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients.","volume":"30","author":"Tanabe","year":"1998","journal-title":"Transplant Proc"},{"key":"R39-1-20210129","first-page":"189","article-title":". Human T lymphotropic virus 1-2 positive antibodies in potential organ donors in France.","volume":"28","author":"Claquin","year":"1996","journal-title":"Transplant Proc"},{"key":"R40-1-20210129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jmv.20331","article-title":". Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain.","volume":"76","author":"Toro","year":"2005","journal-title":"J Med Virol"},{"key":"R41-1-20210129","first-page":"658","article-title":"Human T-cell lymphotrophic virus infection in organ donors: a need to reassess policy Am J T","volume":"2","author":"Shames","year":"2002","journal-title":"ransplant"},{"key":"R42-1-20210129","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-6143.2009.02867.x","article-title":". Donor screening for human T-cell lymphotrophic virus 12: changing paradigms for changing testing capacity.","volume":"10","author":"Kaul","year":"2010","journal-title":"Am J Transplant"},{"key":"R43-1-20210129","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.transproceed.2005.03.132","article-title":". Prognosis of HTLV-I-positive renal transplant recipients.","volume":"37","author":"Nakamura","year":"2005","journal-title":"Transplant Proc"},{"key":"R44-1-20210129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1348-0421.1994.tb01811.x","article-title":". Human T cell leukemia virus type 1 (HTLV-1) antibodies in healthy populations and renal transplanted patients in the north-east of Brazil.","volume":"38","author":"Linhares","year":"1994","journal-title":"Microbiol Immunol"},{"key":"R45-1-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1432-2277.2012.01434.x","article-title":". Human T-cell leukemia virus type 1 infection worsens prognosis of hepatitis C virus-related living donor liver transplantation.","volume":"25","author":"Ichikawa","year":"2012","journal-title":"Transpl Int"},{"key":"R46-1-20210129","first-page":"35","article-title":". HIV-1 and HTLV-I infection in renal transplant recipients.","volume":"3","author":"Perez","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R47-1-20210129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5692\/clinicalneurol.50.241","article-title":". Case report of HTLV-1 associated myelopathy (HAM) manifested after renal transplantation.","volume":"50","author":"Inose","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"R48-1-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-510X(00)00332-4","article-title":". HTLV-I-associated myelopathy manifested after renal transplantation.","volume":"177","author":"Nakatsuji","year":"2000","journal-title":"J Neurol Sci"},{"key":"R49-1-20210129","first-page":"1180","article-title":"Kwarteng K, et al..","volume":"87","author":"Marvin","year":"2009","journal-title":"Increasing utilization of human T-cell lymphotropic virus () donors in liver transplantation: is it safe Transplantation"},{"key":"R50-1-20210129","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/21.4.992","article-title":". Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemialymphoma during immunosuppressive treatment following renal transplantation.","volume":"21","author":"Jenks","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R51-1-20210129","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.2830410414","article-title":". Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient.","volume":"41","author":"Tsurumi","year":"1992","journal-title":"Am J Hematol"},{"key":"R52-1-20210129","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000168722","article-title":". Adult T-cell leukemialymphoma in a renal transplant recipient: an opportunistic occurrence.","volume":"14","author":"Williams","year":"1994","journal-title":"Am J Nephrol"},{"key":"R53-1-20210129","first-page":"137","article-title":"Adult T-cell leukaemia following ABO incompatible renal transplantation: a case report.","volume":"12","author":"Mori","year":"2000","journal-title":"Renal Transpl Vasc Surg"},{"key":"R54-1-20210129","first-page":"286","article-title":". One case of HAM after cadavaric renal transplantation.","volume":"36","author":"Shintani","year":"2001","journal-title":"Ishoku"},{"key":"R55-1-20210129","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1046\/j.1537-2995.2000.40111421.x","article-title":". Transmission of HTLV-I by kidney transplant.","volume":"40","author":"Remesar","year":"2000","journal-title":"Transfusion"},{"key":"R56-1-20210129","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/lt.21414","article-title":". Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation.","volume":"14","author":"Soyama","year":"2008","journal-title":"Liver Transpl"},{"key":"R57-1-20210129","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/01.tp.0000235186.30113.c7","article-title":". Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation.","volume":"82","author":"Kawano","year":"2006","journal-title":"Transplantation"},{"key":"R58-1-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1532\/IJH97.05158","article-title":". Adult T-cell leukemia in a liver transplant recipient that did not progress after onset of graft rejection.","volume":"83","author":"Suzuki","year":"2006","journal-title":"Int J Hematol"},{"key":"R59-1-20210129","first-page":"5692S","article-title":". Epidemiology and immunovirology of human T-cell leukemialymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France.","volume":"50","author":"Gessain","year":"1990","journal-title":"Cancer Res"},{"key":"R60-1-20210129","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/338868","article-title":". Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient.","volume":"34","author":"Ozden","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R61-1-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtcvs.2008.12.050","article-title":"Transmission of human T-lymphotropic virus type I by bilateral living-donor lobar lung transplantation.","volume":"138","author":"Yara","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R64-1-20210129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/TP.0b013e3181ffb9bb","article-title":"Screening of deceased organ donors: no easy answers.","volume":"91","author":"Huang","year":"2011","journal-title":"Transplantation"},{"key":"R65-1-20210129","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1097\/00007890-199706270-00014","article-title":"Results of a survey of infectious disease testing practices by organ procurement organizations in the United States.","volume":"63","author":"Domen","year":"1997","journal-title":"Transplantation"},{"key":"R66-1-20210129","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cld.2011.08.006","article-title":"Extended donors in liver transplantation.","volume":"15","author":"Harring","year":"2011","journal-title":"Clin Liver Dis"},{"key":"R68-1-20210129","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0145-2126(90)90172-6","article-title":"Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits.","volume":"14","author":"Isono","year":"1990","journal-title":"Leukemia Res"},{"key":"R69-1-20210129","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2010-02-270751","article-title":". Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.","volume":"116","author":"Afonso","year":"2010","journal-title":"Blood"},{"key":"R70-1-20210129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/v3050469","article-title":". Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors.","volume":"3","author":"Macchi","year":"2011","journal-title":"Viruses"},{"key":"R71-1-20210129","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/AAC.01413-10","article-title":"Integrase inhibitors effective against human T-cell leukemia virus type 1.","volume":"55","author":"Seegulam","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R72-1-20210129","first-page":"161","article-title":"Prospects for the management of human T-cell lymphotropic virus type 1-associated myelopathy.","volume":"13","author":"Martin","year":"2011","journal-title":"AIDS Rev"},{"key":"R73-1-20210129","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1099\/0022-1317-78-5-1007","article-title":". AZT inhibits the transmission of human T cell leukaemialymphoma virus type I to adult peripheral blood mononuclear cells in vitro.","volume":"78","author":"Macchi","year":"1997","journal-title":"J Gen Virol"},{"key":"R74-1-20210129","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1600-6143.2009.02684.x","article-title":". Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs.","volume":"9","author":"Tricot","year":"2009","journal-title":"Am J Transplant"},{"key":"R75-1-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2047-783X-14-S3-43","article-title":"Raltegravir use in special populations.","volume":"14","author":"Johnson","year":"2009","journal-title":"Eur J Med Res"},{"key":"R76-1-20210129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jac\/dkr404","article-title":". Antiviral effect of raltegravir on HTLV-1 carriers.","volume":"67","author":"Trevino","year":"2012","journal-title":"J Antimicrob Chemother"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-201212150-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:47:28Z","timestamp":1618278448000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201212150-00001"}},"subtitle":["Current Challenges and Future Management Strategies"],"short-title":[],"issued":{"date-parts":[[2012,12,15]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318263ad7a","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12,15]]}}}